Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Dec;28(12):3347-3354.
doi: 10.1007/s11136-019-02284-9. Epub 2019 Sep 3.

Factors associated with quality of life in systemic sclerosis: a cross-sectional study

Affiliations
Multicenter Study

Factors associated with quality of life in systemic sclerosis: a cross-sectional study

Matylda Sierakowska et al. Qual Life Res. 2019 Dec.

Abstract

Introduction: Systemic sclerosis (SSc) is a connective tissue disease characterized by progressive fibrosis of the skin and internal organs, leading to their failure and disturbances in the morphology and function of blood vessels. The disease affects people in different ways, and identifying how the difficulties and limitations are related to quality of life may contribute to designing helpful interventions. The aim of this study was to identify factors associated with quality of life in people with SSc.

Methods: This was a cross-sectional study conducted in 11 rheumatic centres in Poland. Patients diagnosed with SSc were included. Quality of life was measured using the SSc Quality of Life Questionnaire (SScQoL). The following candidate factors were entered in preliminary multivariable analysis: age, place of residence, marital status, occupational status, disease type, disease duration, pain, fatigue, intestinal problems, breathing problems, Raynaud's symptoms, finger ulcerations, disease severity, functional disability, anxiety and depression. Factors that achieved statistical significance at the 10% level were then entered into a final multivariable model. Factors achieving statistical significance at the 5% level in the final model were considered to be associated with quality of life in SSc.

Results: In total, 231 participants were included. Mean age (SD) was 55.82 (12.55) years, disease duration 8.39 (8.18) years and 198 (85.7%) were women. Factors associated with quality of life in SSc were functional disability (β = 2.854, p < 0.001) and anxiety (β = 0.404, p < 0.001). This model with two factors (functional disability and anxiety) explained 56.7% of the variance in patients with diffuse SSc and 73.2% in those with localized SSc.

Conclusions: Functional disability and anxiety are significantly associated with quality of life in SSc. Interventions aimed at improving either of these factors may contribute towards improving the quality of life of people with SSc.

Keywords: Anxiety; Physical disability; Quality of life; Systemic sclerosis.

PubMed Disclaimer

Conflict of interest statement

Author M.S. declares that she has no conflict of interest. Author H.D. declares that she has no conflict of interest. Author J.S. declares that she has no conflict of interest. Author M.O. declares that she has no conflict of interest. Author A.G-J. declares that she has no conflict of interest. Author M.B. declares that he has no conflict of interest. Author P.L. declares that he has no conflict of interest. Author K.P-B. declares that she has no conflict of interest. Author B.B. declares that he has no conflict of interest. Author P.W. declares that he has no conflict of interest. Author M.M. declares that she has no conflict of interest. Author M.B-S. declares that she has no conflict of interest. Author W.R. declares that he has no conflict of interest. Author A.Z.-G. declares that she has no conflict of interest. Author S.J. declares that he has no conflict of interest. Author M.N. declares that he has no conflict of interest.

Similar articles

Cited by

References

    1. Kulikowski K. Quality of life in the context of psychology and medicine. Reumatologia. 2014;52(3):200–206. doi: 10.5114/reum.2014.44091. - DOI
    1. Sierakowski S, Sierakowska M. Systemic sclerosis. In: Zimmermann-Górska I, editor. Advances in clinical rheumatology. Warszawa: Wydawnictwo Lekarskie PZWL; 2014. pp. 189–212.
    1. Sierakowski S, Sierakowska M. Systemic sclerosis. In: Gajewski P, editor. Interstitial Szczeklika 2016, Handbook of internal diseases. Kraków: Medycyna Praktyczna; 2016. pp. 1955–1963.
    1. Clements PJ, Frust DF. Systemic sclerosis. 2. Philadelphia: Lipincott Williams & Wilkins; 2004.
    1. Ranque B, Mouthon L. Geoepidemiology of systemic sclerosis. Autoimmunity Reviews. 2010;9:A311–A318. doi: 10.1016/j.autrev.2009.11.003. - DOI - PubMed

Publication types